pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·5h ago·1 min read
save

Call to unify MD and DO medical education pathways

Aug 5, 2026·read at STAT ↗Positive

Physicians Abigail MacKenzie and Vijay Rajput argue that keeping medical education split between allopathic (MD) and osteopathic (DO) tracks is an outdated practice that adds no value to patient care.

They point to research published in JAMA Surgery and the Annals of Internal Medicine showing no significant differences in mortality, readmissions, or length of stay between patients treated by MD‑trained versus DO‑trained surgeons and hospitalists.

The authors call for a single accreditation system and licensing pathway, saying that a unified training pipeline would reflect the reality that doctors, regardless of their degree, perform the same clinical duties and hold the same state licenses.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: Tear down the wall between M.D. and D.O. education”

read at STAT ↗
1,249 words · retrieved 4h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
RISING
topics
ALSDrug ShortageOrthopedicsPainType 2 Diabetes

related stories

  • Jun 30Opinion: Short-sighted new student loan caps elevate chiropractic care over critical health care professionsSTAT
  • 1d agoOpinion: How Josée became one of the 7.9% of Québécois who die by assisted suicideSTAT
  • 1d agoLatigo laces up for $247M IPO to fund non-opioid pain drug rival to Vertex’s JournavxFierce Biotech
  • 5d agoSyphilis spreads while researchers contend with federal constraints and a drug shortageSTAT
  • Jul 23Lilly’s triple-G drug hits 22.6% weight loss, but impact on reducing cardio risk is less clearFierce Biotech